文献速递心脑血管急症儿科与产科急症重症综合管理与镇静镇痛

血红蛋白容量相位指数与新生儿缺氧缺血性脑病磁共振成像及功能结局关系的探索性评估

Exploratory Assessment of the Relationship Between Hemoglobin Volume Phase Index, Magnetic Resonance Imaging, and Functional Outcome in Neonates with Hypoxic-Ischemic Encephalopathy.
PubMed 文献 · Neurocrit Care · 2020-11-20
一句话结论在50例中重度HIE接受亚低温治疗的新生儿中,HVP在生后21-27小时可预测死亡或MRI严重脑损伤及远期发育迟缓,属初步探索性发现。

本研究为单中心前瞻性试点研究,纳入50例中重度HIE并接受亚低温治疗的新生儿,在亚低温及复温期间持续监测脑NIRS与有创动脉MAP,用多变量自回归模型计算MAP与HbT的相干性并得出HVP。结果显示不良结局组HVP中位数更高;校正性别与入院脑病分级后,生后21-24小时及24-27小时HVP可预测死亡或MRI脑损伤(OR 8.8,p=0.037;OR 31,p=0.011)及死亡或15-30月发育迟缓(OR 11.8,p=0.05;OR 15,p=0.035)。作者结论为HVP值得进一步研究,尚需更大样本验证。

要点

  • 生后24-27小时HVP预测死亡或MRI严重脑损伤的校正OR为31(p=0.011),是原文中效应最强的时点。
  • 生后21-24小时HVP预测死亡或MRI脑损伤校正OR 8.8(p=0.037),预测死亡或发育迟缓OR 11.8(p=0.05)。
  • 生后24-27小时HVP预测死亡或15-30月发育迟缓校正OR 15(p=0.035)。
  • HVP越高代表自主调节功能越差,不良结局组HVP中位数更高。
  • 该指标目前仅为试点研究结论,原文明确需更大样本进一步临床验证,尚不能作为床旁决策阈值。

适用人群与场景

  • 单中心四级NICU中患中重度缺氧缺血性脑病并接受亚低温治疗的新生儿,共50例;监测覆盖亚低温期间及复温全过程。

诊断标准与关键阈值

  • 脑损伤评估采用新生儿磁共振成像(MRI);发育结局采用Bayley婴幼儿发育量表第三版(BSID-III)在15-30月龄评估。
  • HVP由MAP与氧合及脱氧血红蛋白密度总和(HbT,作为脑血容量替代指标)在最大MAP-HbT相干频率处的相位差经余弦变换计算,采用多变量自回归过程。
  • 原文未给出HVP的临床决策阈值或启动/停止界值。

处置流程与药物剂量

  • 第一步:对中重度HIE新生儿按原文方案实施亚低温治疗(TH)。
  • 第二步:经留置动脉导管持续监测平均动脉压(MAP),同时持续进行脑近红外光谱(NIRS)监测。
  • 第三步:在亚低温期间及复温全程采集数据,用多变量自回归过程计算MAP与HbT相干性并得出HVP。
  • 第四步:生后21-24小时及24-27小时HVP结合性别与入院脑病分级进行风险分层评估(原文为研究性分析,非临床推荐流程)。
  • 原文未提及具体药物剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • HVP升高提示自主调节功能障碍,与死亡或MRI严重脑损伤及远期发育迟缓风险相关,原文未给出据此启动的具体处理措施。

研究设计与关键结果

  • 研究类型:单中心前瞻性试点研究,样本量50例中重度HIE接受亚低温治疗的新生儿。
  • 干预/方法:持续脑NIRS与有创动脉MAP监测,多变量自回归计算MAP-HbT相干性得出HVP;结局为新生儿MRI脑损伤及15-30月BSID-III发育评估。
  • 主要终点:校正性别与入院脑病分级后,生后21-24小时HVP预测死亡或MRI脑损伤OR 8.8(p=0.037),24-27小时OR 31(p=0.011)。
  • 关键次要终点:生后21-24小时HVP预测死亡或发育迟缓OR 11.8(p=0.05),24-27小时OR 15(p=0.035)。

证据类型、等级与局限

  • 证据类型:单中心前瞻性试点研究(pilot study),原文未给出正式证据等级或推荐强度。
  • 局限:单中心、样本量小(50例)、探索性分析;原文结论明确需更大样本进一步临床验证。

对床旁实践的改变

  • 提示在四级NICU对中重度HIE亚低温治疗新生儿,生后21-27小时HVP可能作为死亡或MRI严重脑损伤及远期发育迟缓的早期风险标志,但当前仅为研究性指标。
  • 原文明确该指标尚未进入临床实践,不改变现有HIE亚低温治疗与监测流程;不适用于未接受亚低温或非中重度HIE人群(原文未纳入)。
  • 常见陷阱:将试点研究的OR值误作临床决策阈值,或在无动脉导管和有创血压监测条件下外推该指标。

指南或共识出处

  • 原文未提及具体指南或共识名称;文献来源为Neurocrit Care。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND/OBJECTIVE: Near-infrared spectroscopy (NIRS)-based measures of cerebral autoregulation (CAR) can potentially identify neonates with hypoxic-ischemic encephalopathy (HIE) who are at greatest risk of irreversible brain injury. However, modest predictive abilities have precluded previously described metrics from entering clinical care. We previously validated a novel autoregulation metric in a piglet model of induced hypotension called the hemoglobin volume phase index (HVP). The objective of this study was to evaluate the clinical ability of the HVP to predict adverse outcomes neonates with HIE.

METHODS: This is a prospective study of neonates with HIE who underwent therapeutic hypothermia (TH) at a level 4 neonatal intensive care unit (NICU). Continuous cerebral NIRS and mean arterial blood pressure (MAP) from indwelling arterial catheters were measured during TH and through rewarming. Multivariate autoregressive process was used to calculate the coherence between MAP and the sum total of the oxy- and deoxygenated Hb densities (HbT), a surrogate measure of cerebral blood volume (CBV). The HVP was calculated as the cosine-transformed phase shift at the frequency of maximal MAP-HbT coherence. Brain injury was assessed by neonatal magnetic resonance imaging (MRI), and developmental outcomes were assessed by the Bayley Scales of Infant Development (BSID-III) at 15-30 months. The ability of the HVP to predict (a) death or severe brain injury by MRI and (b) death or significant developmental delay was assessed using logistic regression analyses.

RESULTS: In total, 50 neonates with moderate or severe HIE were monitored. Median HVP was higher, representing more dysfunctional autoregulation, in infants who had adverse outcomes. After adjusting for sex and encephalopathy grade at presentation, HVP at 21-24 and 24-27 h of life predicted death or brain injury by MRI (21-24 h: OR 8.8, p = 0.037; 24-27 h: OR 31, p = 0.011) and death or developmental delay at 15-30 months (21-24 h: OR 11.8, p = 0.05; 24-27 h: OR 15, p = 0.035).

CONCLUSIONS: Based on this pilot study of neonates with HIE, HVP merits further study as an indicator of death or severe brain injury on neonatal MRI and neurodevelopmental delay in early childhood. Larger studies are warranted for further clinical validation of the HVP to evaluate cerebral autoregulation following HIE.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Massaro AN, Lee JK, Vezina G, et al. Exploratory Assessment of the Relationship Between Hemoglobin Volume Phase Index, Magnetic Resonance Imaging, and Functional Outcome in Neonates with Hypoxic-Ischemic Encephalopathy. Neurocrit Care. 2020. PMID: 33215394. doi:10.1007/s12028-020-01150-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。